Solesence (SLSN) Stock Price, News & Analysis

Company Overview

Nanophase Technologies Corporation provides engineered materials, formulation development, and commercial manufacturing with an integrated family of technologies in the United States. It offers surface engineered zinc oxide and titanium dioxide for sunscreens and personal care products; fully formulated cosmetics, sun care, and skin care under the Solésence brand name; and advanced materials products, such as architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics, and various surface finishing technologies applications. The company was incorporated in 1989 and is headquartered in Romeoville, Illinois.

Key Stats

• Today's Range: $1.02 to $1.05
• 50-Day Range: $0.64 to $1.36
• 52-Week Range: $0.61 to $4.55
• Volume: 2,943 shs
• Average Volume: 38,977 shs
• Market Capitalization: $72.04 million
• P/E Ratio: 102.10
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Solesence Stock Analysis - MarketRank™

Solesence scored higher than 11% of companies evaluated by MarketBeat, and ranked 165th out of 171 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Solesence has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Solesence has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Solesence is 102.10, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.93.

Price to Earnings Ratio vs. Sector

The P/E ratio of Solesence is 102.10, which means that it is trading at a more expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 13.38.

Price to Book Value per Share Ratio

Solesence has a P/B Ratio of 4.08. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.59% of the float of Solesence has been sold short.

Short Interest Ratio / Days to Cover

Solesence has a short interest ratio ("days to cover") of 7.11.

Change versus previous month

Short interest in Solesence has recently decreased by 7.09%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Solesence does not currently pay a dividend.

Dividend Growth

Solesence does not have a long track record of dividend growth.

News and Social Media

• Score: 2.3 / 5
• News Sentiment: 0.63

News Sentiment

Solesence has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Consumer Staples companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Solesence this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.9 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Solesence insiders have not sold or bought any company stock.

Percentage Held by Insiders

4.80% of the stock of Solesence is held by insiders.

Percentage Held by Institutions

70.22% of the stock of Solesence is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 11/13/2025
• Today: 8/15/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Consumer Staples
• Industry: Personal Care Products
• Sub-Industry: Personal Care Products
• Current Symbol: NASDAQ:SLSN
• Previous Symbol: NASDAQ:SLSN
• CIK: 883107
• Web: nanophase.com
• Phone: (630) 323-1200
• Fax: 630-771-0825
• Employees: 60
• Year Founded: 1989

Profitability

• EPS (Trailing Twelve Months): $0.01
• Trailing P/E Ratio: 102.10
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $1.79 million
• Net Margins: 1.56%
• Pretax Margin: 1.68%
• Return on Equity: 5.39%
• Return on Assets: 1.78%

Debt

• Debt-to-Equity Ratio: 0.62
• Current Ratio: 2.08
• Quick Ratio: 0.70

Sales & Book Value

• Annual Sales: $62.06 million
• Price / Sales: 1.16
• Cash Flow: $0.04 per share
• Price / Cash Flow: 26.51
• Book Value: $0.25 per share
• Price / Book: 4.08

Miscellaneous

• Outstanding Shares: 70,630,000
• Free Float: 67,242,000
• Market Cap: $72.04 million
• Optionable: N/A
• Beta: 1.25